Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioceres Crop Solutions (BIOX) Total Current Liabilities (2017 - 2026)

Bioceres Crop Solutions' Total Current Liabilities history spans 10 years, with the latest figure at $297.5 million for Q1 2026.

  • On a quarterly basis, Total Current Liabilities changed N/A to $297.5 million in Q1 2026 year-over-year; TTM through Mar 2026 was $297.5 million, a N/A change, with the full-year FY2025 number at $338.0 million, up 2.64% from a year prior.
  • Total Current Liabilities hit $297.5 million in Q1 2026 for Bioceres Crop Solutions, down from $338.0 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for BIOX hit a ceiling of $338.0 million in Q2 2025 and a floor of $222.7 million in Q2 2022.
  • Historically, Total Current Liabilities has averaged $297.2 million across 5 years, with a median of $298.7 million in 2023.
  • Biggest five-year swings in Total Current Liabilities: soared 34.15% in 2023 and later grew 2.64% in 2025.
  • Tracing BIOX's Total Current Liabilities over 5 years: stood at $222.7 million in 2022, then soared by 34.15% to $298.7 million in 2023, then grew by 10.24% to $329.3 million in 2024, then grew by 2.64% to $338.0 million in 2025, then dropped by 11.98% to $297.5 million in 2026.
  • Business Quant data shows Total Current Liabilities for BIOX at $297.5 million in Q1 2026, $338.0 million in Q2 2025, and $329.3 million in Q2 2024.